131 related articles for article (PubMed ID: 7522996)
1. An improved method for quantification of very long chain fatty acids in plasma.
Vallance H; Applegarth D
Clin Biochem; 1994 Jun; 27(3):183-6. PubMed ID: 7522996
[TBL] [Abstract][Full Text] [Related]
2. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
4. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
5. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Hall NA; Lynes GW; Hjelm NM
Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of peroxisomal disorders with neurological involvement.
Molzer B
Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
[TBL] [Abstract][Full Text] [Related]
8. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
[TBL] [Abstract][Full Text] [Related]
9. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry.
Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):281-7. PubMed ID: 9746242
[TBL] [Abstract][Full Text] [Related]
10. Analysis of very long-chain fatty acids and plasmalogen in the erythrocyte membrane: a simple method for the detection of peroxisomal disorders and discrimination between adrenoleukodystrophy and Zellweger syndrome.
Tanaka K; Nishizawa K; Yamamoto H; Naruto T; Izeki E; Taga T; Shimada M; Saeki Y
Neuropediatrics; 1990 Aug; 21(3):119-23. PubMed ID: 2234315
[TBL] [Abstract][Full Text] [Related]
11. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
12. Postnatal diagnosis of peroxisomal disorders: a biochemical approach.
Wanders RJ; Schutgens RB; Barth PG; Tager JM; van den Bosch H
Biochimie; 1993; 75(3-4):269-79. PubMed ID: 7685190
[TBL] [Abstract][Full Text] [Related]
13. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry.
Valianpour F; Selhorst JJ; van Lint LE; van Gennip AH; Wanders RJ; Kemp S
Mol Genet Metab; 2003 Jul; 79(3):189-96. PubMed ID: 12855224
[TBL] [Abstract][Full Text] [Related]
14. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
15. Improved determination of very-long-chain fatty acids in plasma and cultured skin fibroblasts: applications to the diagnosis of peroxisomal disorders.
Onkenhout W; van der Poel PF; van den Heuvel MP
J Chromatogr; 1989 Sep; 494():31-41. PubMed ID: 2479651
[TBL] [Abstract][Full Text] [Related]
16. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
17. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
18. Complementation analysis of peroxisomal disorders and classical Refsum.
Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
[No Abstract] [Full Text] [Related]
19. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical characteristics of peroxisomal disorders: an update.
Wanders RJ; Barth PG; Schutgens RB; Tager JM
Eur J Pediatr; 1994; 153(7 Suppl 1):S44-8. PubMed ID: 7957386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
